Background
==========

Glucocorticoids (GCs) are a class of steroid hormones involved in many essential biological processes. Due to their profound anti-inflammatory and immunosuppressive properties, these hormones are utilized in a variety of disease treatments \[[@b1-medscimonit-25-5501]\]. GCs mediate expression of targeted genes through binding to glucocorticoid receptors (GRs) to induce pharmacodynamic actions \[[@b2-medscimonit-25-5501]\]. Dexamethasone (DEX), a representative GC, is widely used around the world. However, prolonged use of GCs may lead to adverse effects such as glaucoma, resulting in manifestations of glaucomatous optic neuropathy and irreversible visual impairment. This pathogenesis shares similarities with primary open-angle glaucoma (POAG) \[[@b3-medscimonit-25-5501]\]. GCs can rearrange the structure of the anterior segment, and GRs have been identified on the surface of trabecular meshwork (TM) cells \[[@b4-medscimonit-25-5501]\]. Treatment with GCs changes the microstructure of the TM, resisting the outflow of aqueous humor (AH) and resulting in elevated intraocular pressure (IOP) \[[@b5-medscimonit-25-5501]--[@b7-medscimonit-25-5501]\]. The precise pathogenesis of GCs-induced glaucoma (GIG) has not been thoroughly elucidated to date, and researchers are attempting to learn more about this disease.

A previous study suggested that the actin cytoskeleton could be rearranged into cross-linked actin networks (CLANs) in cultured anterior segments and cultured TM cells treated with DEX, disrupting the balance of normal fluid flow \[[@b8-medscimonit-25-5501]\]. Many factors mediate this alternation. Integrins can form complexes with various molecules, and these supra-molecular complexes establish bidirectional signaling between the extracellular and intracellular environment. This process regulates changes in the actin cytoskeleton \[[@b9-medscimonit-25-5501]\]. Enhanced β3 integrin signaling was proposed to play a role in DEX-induced CLAN formation \[[@b10-medscimonit-25-5501]\]. Members of the Ras homolog (Rho) family of small guanosine triphosphatases (GTPases) also regulate organization of the actin cytoskeleton \[[@b11-medscimonit-25-5501]\]. Ras homolog family member A (RhoA) is increased in GC-treated trabecular meshwork (TM)-1 cells \[[@b12-medscimonit-25-5501]\]. In addition, cell division cycle 42 (Cdc42), another member of the Rho family GTPases, is also overexpressed in DEX-treated TM-1 cells \[[@b13-medscimonit-25-5501]\]. Recently, several new mechanisms have been proposed. Overexpression of a-smooth muscle actin (aSMA) and activation of the mitogen-activated protein kinase (MAPK) pathway stiffens the extracellular matrix (ECM) in DEX-treated TM cells \[[@b14-medscimonit-25-5501]\].

It is widely accepted that vision can be impaired in response to elevated IOP, and gradual elevation of IOP makes diagnosing DEX-induced glaucoma difficult. Therefore, it is urgent to study the pathogenesis of DEX-induced glaucoma to formulate proper diagnostic, therapeutic, and preventive tactics. Bioinformatics analysis of microarray data can identify differentially expressed genes (DEGs) between disease and control groups to identify important genes and pathways involved in the disease process. In this study, the expression profile GSE37474 was analyzed using bioinformatics. There are no relevant publications on this database, and, to the best of our knowledge, this database has not previously been analyzed.

Material and Methods
====================

Gene expression data
--------------------

The gene expression profile GSE37474 was obtained from the public Gene Expression Omnibus database (GEO, *<https://www.ncbi.nlm.nih.gov/geo/>*). GSE37474 was utilized on the basis of the GPL570 platform (Affymetrix Human Genome U113 Plus 2.0 Array; Agilent Technologies, Santa Clara, CA, USA). GSE37474 contains 5 experimental samples and 5 control samples, and all samples were obtained from 5 paired donor eyes. For each paired sample, the anterior segment of one eye was cultured containing DEX, while the ipsilateral anterior segment was cultured in the absence of DEX.

Identification of differentially expressed genes
------------------------------------------------

GEO2R (*<http://www.ncbi.nlm.nih.gov/geo/geo2r/>*), an R programming language-based online tool, was employed to screen DEGs by comparing samples from the GEO series \[[@b15-medscimonit-25-5501]\]. We used GEO2R to identify DEGs in DEX-treated tissues and control tissues. P\<0.05 and log fold change (FC) ≥1 were used as threshold criteria for DEGs. A heatmap was constructed using HemI1.0 software, and a volcano plot was constructed using R software.

Functional enrichment analysis
------------------------------

Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were performed to determine the functions of DEGs using the Database for Annotation, Visualization and Integrated Discovery (DAVID) (*<https://david.ncifcrf.gov/>*). GO terms included molecular functions, cellular components, and biological processes of genomic products \[[@b16-medscimonit-25-5501]\]. KEGG analyzes pathways of important gene products \[[@b17-medscimonit-25-5501]\]. DAVID is a bioinformatics database for analyzing the functional interpretation of lists of proteins and genes \[[@b18-medscimonit-25-5501]\]. The cutoff value was set to P\<0.05.

Protein--protein interaction network construction and module screening
----------------------------------------------------------------------

The Search Tool for the Retrieval of Interacting Genes (STRING) database (*<http://string-db.org/>*) is an analysis tool that predicts comprehensive interactions of lists of genes at the protein level \[[@b19-medscimonit-25-5501]\]. In our study, a PPI network of DEGs was analyzed by STRING and presented using Cytoscape software. Then, 10 hub genes were identified by the cytoHubba plugin. Molecular Complex Detection (MCODE) analysis of the PPI network was performed using Cytoscape, and MCODE scores \>3 and number of nodes \>4 were set as cutoff criteria.

Results
=======

Identification of DEGs
----------------------

We identified 252 DEGs in the GSE37474 dataset using the GEO2R tool. Of these DEGs, 143 genes were upregulated and 109 genes were downregulated. The top 5 upregulated and downregulated DEGs are shown in [Table 1](#t1-medscimonit-25-5501){ref-type="table"}. The volcano plot and heatmap for DEGs are illustrated in [Figure 1A and 1B](#f1-medscimonit-25-5501){ref-type="fig"}, respectively.

DEG analyses via GO and KEGG
----------------------------

GO enrichment and KEGG pathway analyses of identified DEGs were conducted by DAVID. The analysis results of significantly enriched GO terms are shown in [Table 2](#t2-medscimonit-25-5501){ref-type="table"}. In terms of molecular functions, a number of upregulated genes were involved in calcium ion binding, while many downregulated genes functioned in cytokine activity. According to cellular components, many upregulated and downregulated genes were located in the extracellular region. In addition, biological processes analysis revealed that upregulated genes primarily participated in extracellular matrix (ECM) organization and cholesterol homeostasis, while downregulated genes were mostly enriched in the inflammatory response. Furthermore, KEGG pathway results are displayed in [Table 3](#t3-medscimonit-25-5501){ref-type="table"}. For upregulated genes, tyrosine metabolism and ECM-receptor interaction were involved in many gene products. For downregulated genes, cytokine-cytokine receptor interaction and inflammatory mediator regulation of TRP channels were most significant.

Screening of hub genes and analysis of modules
----------------------------------------------

The PPI network of DEGs was constructed, with 133 nodes and 259 edges being mapped ([Figure 2](#f2-medscimonit-25-5501){ref-type="fig"}). The 10 hub genes were determined by CytoHubba plugin using the MCC method and included CCL2, FOS, IGF1, PTGS2, CCL5, EDN1, IL11, F3, PMCH, and BDKRB1 ([Figure 3](#f3-medscimonit-25-5501){ref-type="fig"}). Details for hub genes are displayed in [Table 4](#t4-medscimonit-25-5501){ref-type="table"}. Hub genes consisted of 3 upregulated genes and 7 downregulated genes. MCODE analysis was performed, and 2 modules were chosen from the PPI network using Cytoscape software ([Figure 4](#f4-medscimonit-25-5501){ref-type="fig"}). In addition, IL11 and FOS were 2 seed genes for the chosen modules in MCODE analysis. KEGG pathway enrichment analysis revealed that module genes were primarily involved in the TNF signaling pathway, cytokine-cytokine receptor interaction, and the Jak-STAT signaling pathway ([Figure 5](#f5-medscimonit-25-5501){ref-type="fig"}).

Discussion
==========

The pathogenesis of DEX-induced glaucoma has been difficult to explain. In this study, we identified 252 DEGs, 143 upregulated and 109 downregulated, in the GSE 37474 dataset. According to results from the GO analysis, DEGs were primarily located in the extracellular region. At the level of biological processes, numerous DEGs participated in ECM organization and cholesterol homeostasis. These results suggest that ECM organization is of great significance. The ECM of TM plays an important role in regulating IOP. Previous studies have demonstrated that many ECM components change within the TM in DEX-induced glaucoma \[[@b20-medscimonit-25-5501],[@b21-medscimonit-25-5501]\]. Recently, studies have reported that stains can increase aqueous outflow, delaying the progression of open-angle glaucoma \[[@b22-medscimonit-25-5501]\]. Furthermore, cholesterol-lowering medications may inhibit the production of isoprenoid intermediates in the cholesterol biosynthetic pathway, indirectly suppressing Rho GTPase signaling \[[@b22-medscimonit-25-5501]\]. Based on these findings, it is tempting to speculate that cholesterol homeostasis is associated with the development of DEX-induced glaucoma. Additionally, KEGG pathway enrichment analysis indicated that tyrosine metabolism and ECM-receptor interaction were significantly enriched pathways in DEX-induced glaucoma. Tyrosine metabolism is attracting the attention of many investigators. Numerous studies have shown that protein phosphorylation can mediate cellular functions in a variety of life activities \[[@b23-medscimonit-25-5501],[@b24-medscimonit-25-5501]\]. Vertebrate lonesome kinase (VLK) is a secretory tyrosine kinase that phosphorylates various ECM proteins \[[@b25-medscimonit-25-5501]\], and DEX reportedly increases the expression of VLK in human TM cells, thereby regulating tyrosine phosphorylation (TyrP) of ECM proteins \[[@b26-medscimonit-25-5501]\]. Thus, the homeostasis of AH outflow becomes disrupted. These enriched pathways may contribute to elucidating the pathogenesis of DEX-induced glaucoma and thus provide clues to the formulation of new therapeutic methods.

Serum amyloid A (SAA) genes include SAA1, SAA2, SAA3, and SAA4. SAA1 and SAA2 are stimulated by proinflammatory cytokines. Our study revealed significant differences in expression of SAA genes between DEX-treated anterior segment and the control anterior segment. This outcome is consistent with a previous study \[[@b27-medscimonit-25-5501]\], leading us to speculate that these genes interfere with AH outflow. However, the physiological role of SAA genes in glaucoma remains elusive. SSA genes take part in a number of biological processes, including infection, inflammation, and tissue remolding, and the liver is an important location for SAA synthesis \[[@b28-medscimonit-25-5501]\]. In addition, macrophages, smooth muscle cells, and endothelial cells are also involved in the production of SAA \[[@b29-medscimonit-25-5501]\]. Acute-phase SAA (A-SAA) is encoded by SAA1/SAA2. Recombinant human A-SAA induces matrix metalloproteinase transcription \[[@b30-medscimonit-25-5501]\]. Furthermore, it has been reported that recombinant SAA1 has chemoattractant properties *in vivo* \[[@b31-medscimonit-25-5501]\]. These biological effects may elucidate the etiological role of SAA genes in DEX-induced glaucoma.

Among the 10 hub genes identified, chemokine (C-C motif) ligand 2 (CCL2) showed the highest degree. Several cells types, such as endothelial, fibroblasts, and monocytes, secrete CCL2, which is also known as monocyte chemotactic protein-1 (MCP-1) \[[@b32-medscimonit-25-5501]\]. Normal trabecular meshwork endothelial (TME) cells secrete considerable quantities of MCP1 in the absence of stimulus, and levels are increased in glaucomatous human TME cells \[[@b33-medscimonit-25-5501]\]. Another study demonstrated that MCP-1 increases AH outflow through altering cell-cell contact in Schlemm's canal endothelial cells \[[@b34-medscimonit-25-5501]\]. Interestingly, some previous studies have proposed that GCs modulate the expression of MCP-1. Glucocorticoid-induced leucine zipper (GILZ) is a glucocorticoid-induced protein that affects anti-inflammatory processes \[[@b35-medscimonit-25-5501]\]. One study indicated that exogenous GILZ inhibits lipopolysaccharide-induced MCP-1 expression in rat retinal vascular endothelial cells through enhancing p65 dephosphorylation \[[@b36-medscimonit-25-5501]\]. In another study, investigators posited that GCs downregulated expression of CCL2 in lens epithelial cells, suggesting a potential role for CCL2 in GC-induced cataracts \[[@b37-medscimonit-25-5501]\]. Furthermore, this study also showed that the transcription factor c-Jun binds to the promoter regions of CCL2 to mediate its expression in the pathogenesis of GC-induced cataracts \[[@b37-medscimonit-25-5501]\]. Hence, we conclude that CCL2 may participate in a variety of biological processes. The physiological role of CCL2 in GC-induced glaucoma requires further investigation. In addition to CCL2, endothelin 1 (EDN1) is another significant hub gene. EDN1 is a peptide of 21 amino acids produced by cardiac myocytes and vascular endothelial cells. Nonpigmented ciliary epithelial cells could be one possible source for EDN1 production in ocular tissues \[[@b38-medscimonit-25-5501]\]. EDN1 is found in AH, and its concentration is elevated in POAG patients \[[@b39-medscimonit-25-5501]\]. A previous study revealed that GCs stimulate the expression of EDN1 in renal collecting duct cells \[[@b40-medscimonit-25-5501]\]. Thus, GCs may stimulate the EDN1 to modulate the AH outflow.

We extracted 2 modules from the PPI network through MCODE analysis. Among the genes presented in the modules, we are particularly interested in parathyroid hormone-like hormone (PTHLH). The TM has a characteristic flexible layer-like structure that maintains normal function. Calcification may be involved in the pathophysiological process of the TM since this tissue has been reported to contain calcification markers \[[@b41-medscimonit-25-5501],[@b42-medscimonit-25-5501]\]. PTHLH participates in calcium and phosphate homeostasis and is downregulated by vitamin D3 \[[@b43-medscimonit-25-5501]\]. PTHLH may be an inhibitor of calcification. It was previously indicated that DEX downregulated expression of PLHTH in human TM cells \[[@b27-medscimonit-25-5501]\]. Thus, the pathological role of PTHLH in DEX-induced glaucoma merits further investigation.

Conclusions
===========

DEGs and pathways associated with DEX-induced glaucoma were identified in this study using bioinformatics analyses. In this work, tyrosine metabolism, cholesterol homeostasis, and ECM organization were revealed to be important mechanisms of DEX-induced glaucoma. SAA, CCL2, EDN1, and PTHLH could be potential biomarkers of GIG, which may contribute to improving diagnostic, therapeutic, and preventive methods. Our study provides greater understanding of the gene expression profile in the anterior segment of the human eye induced by DEX. Further experiments are required to verify the present findings in the near future.
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###### 

The top 5 upregulated and downregulated DEGs obtained from GSE37474 dataset.

                  Gene symbol               log FC      P value
  --------------- ------------------------- ----------- ----------
  Upregulated     SAA2-SAA4///SAA2///SAA1   4.9916146   2.23E-05
  IL1R2           4.147068                  1.57E-05    
  ZBTB16          4.0130764                 7.79E-07    
  P2RY14          3.903948                  4.84E-05    
  SAA2///SAA1     3.5531796                 6.20E-05    
  Downregulated   TFPI2                     −2.354117   2.40E-04
  TNFRSF11B       −2.371862                 2.36E-05    
  CCL7            −2.551654                 6.70E-04    
  IL24            −2.770583                 3.72E-03    
  FAM150B         −3.3337                   1.83E-07    

###### 

Functional enrichment analysis of DEGs.

  Expression         Category                                                           Term                               Count      P value
  ------------------ ------------------------------------------------------------------ ---------------------------------- ---------- ----------
  Upregulated        GOTERM_MF_DIRECT                                                   GO: 0005509\~calcium ion binding   13         3.55E-03
  GOTERM_MF_DIRECT   GO: 0004867\~serine-type endopeptidase inhibitor activity          5                                  4.35E-03   
  GOTERM_MF_DIRECT   GO: 0008201\~heparin binding                                       6                                  4.78E-03   
  GOTERM_MF_DIRECT   GO: 0002020\~protease binding                                      5                                  5.02E-03   
  GOTERM_MF_DIRECT   GO: 0005215\~transporter activity                                  6                                  1.24E-02   
  GOTERM_CC_DIRECT   GO: 0005576\~extracellular region                                  34                                 5.43E-09   
  GOTERM_CC_DIRECT   GO: 0070062\~extracellular exosome                                 46                                 9.33E-09   
  GOTERM_CC_DIRECT   GO: 0005578\~proteinaceous extracellular matrix                    14                                 3.61E-08   
  GOTERM_CC_DIRECT   GO: 0005615\~extracellular space                                   26                                 3.51E-06   
  GOTERM_CC_DIRECT   GO: 0031012\~extracellular matrix                                  10                                 1.93E-04   
  GOTERM_BP_DIRECT   GO: 0030198\~extracellular matrix organization                     9                                  7.30E-05   
  GOTERM_BP_DIRECT   GO: 0045926\~negative regulation of growth                         4                                  3.02E-04   
  GOTERM_BP_DIRECT   GO: 0007155\~cell adhesion                                         12                                 3.90E-04   
  GOTERM_BP_DIRECT   GO: 0042632\~cholesterol homeostasis                               5                                  1.06E-03   
  GOTERM_BP_DIRECT   GO: 0010951\~negative regulation of endopeptidase activity         6                                  1.64E-03   
  Downregulated      GOTERM_MF_DIRECT                                                   GO: 0005125\~cytokine activity     11         2.10E-08
  GOTERM_MF_DIRECT   GO: 0008083\~growth factor activity                                9                                  1.70E-06   
  GOTERM_MF_DIRECT   GO: 0005102\~receptor binding                                      9                                  4.34E-04   
  GOTERM_MF_DIRECT   GO: 0005518\~collagen binding                                      4                                  3.54E-03   
  GOTERM_MF_DIRECT   GO: 0008201\~heparin binding                                       5                                  9.04E-03   
  GOTERM_CC_DIRECT   GO: 0005576\~extracellular region                                  30                                 3.24E-09   
  GOTERM_CC_DIRECT   GO: 0005615\~extracellular space                                   27                                 6.46E-09   
  GOTERM_CC_DIRECT   GO: 0005578\~proteinaceous extracellular matrix                    7                                  3.26E-03   
  GOTERM_CC_DIRECT   GO: 0031012\~extracellular matrix                                  6                                  2.18E-02   
  GOTERM_BP_DIRECT   GO: 0006954\~inflammatory response                                 11                                 4.24E-05   
  GOTERM_BP_DIRECT   GO: 0007267\~cell-cell signaling                                   9                                  7.64E-05   
  GOTERM_BP_DIRECT   GO: 0014911\~positive regulation of smooth muscle cell migration   4                                  1.70E-04   
  GOTERM_BP_DIRECT   GO: 0070374\~positive regulation of ERK1 and ERK2 cascade          7                                  4.00E-04   
  GOTERM_BP_DIRECT   GO: 0030593\~neutrophil chemotaxis                                 5                                  4.69E-04   

###### 

The significant KEGG pathway enriched by DEGs.

  Expression                                                   Term                                               Count      P value                                        Genes
  ------------------------------------------------------------ -------------------------------------------------- ---------- ---------------------------------------------- ---------------------------------------------------------
  Upregulated                                                  hsa00350: Tyrosine metabolism                      4          3.04E-03                                       MAOA, AOX1, ADH1B, HPD
  hsa04270: Vascular smooth muscle contraction                 6                                                  3.08E-03   ACTA2, MRVI1, PLA2G5, KCNMB1, PPP1R14A, MYL9   
  hsa00982: Drug metabolism -- cytochrome P450                 4                                                  1.91E-02   FMO2, MAOA, AOX1, ADH1B                        
  hsa04512: ECM-receptor interaction                           4                                                  3.62E-02   LAMA2, ITGB4, SDC4, COL11A1                    
  Downregulated                                                hsa04060: Cytokine-cytokine receptor interaction   8          5.53E-04                                       LIF, TNFRSF11B, CCL2, TNFSF13B, CCL5, CCL7, TGFB2, IL11
  hsa05323: Rheumatoid arthritis                               5                                                  2.26E-03   CCL2, TNFSF13B, CCL5, TGFB2, IL11              
  hsa04750: Inflammatory mediator regulation of TRP channels   5                                                  3.34E-03   PLA2G4A, PLCB4, IGF1, BDKRB1, PLA2G4C          
  hsa04913: Ovarian steroidogenesis                            4                                                  3.62E-03   PLA2G4A, PTGS2, IGF1, PLA2G4C                  
  hsa05142: Chagas disease (American trypanosomiasis)          5                                                  4.14E-03   GNA14, CCL2, PLCB4, CCL5, TGFB2                

###### 

The 10 hub DEGs were obtained by cytoHubba.

  Gene symbol   P Value    Log FC     Score   Degree   Regulation
  ------------- ---------- ---------- ------- -------- ------------
  CCL2          1.20E-02   −1.01584   536     22       Down
  FOS           5.42E-03   1.945081   507     24       Up
  IGF1          3.77E-05   −2.23249   406     24       Down
  PTGS2         1.10E-03   −1.34509   404     17       Down
  CCL5          9.07E-03   −1.59577   401     16       Down
  EDN1          4.62E-02   1.048579   325     13       Up
  IL11          1.16E-05   −1.7911    194     10       Down
  F3            7.83E-03   1.609335   158     10       Up
  PMCH          1.70E-04   −1.97567   54      7        Down
  BDKRB1        2.37E-05   −2.12487   54      7        Down
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